PARIS (Reuters) - French drugmaker Sanofi said on Thursday it plans to close a plant in northern England as it contends with European health spending cuts and growing competition from generic drugs. The Fawdon plant near Newcastle, which makes drugs ... [Full Article]
(Canadian Press) - In this Feb. 10, 2010 file photo, the Sanofi Avantis logo is seen during the presentation of the 2009 full year results in Paris. THE CANADIAN PRESS/AP, Francois Mori... [Full Article]
(AFP/File) - French pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving the offer after an initial deadline expired.(AFP/File/John Macdougall)... [Full Article]
(AFP/File) - A bid by French pharmaceutical giant Sanofi-Aventis for US biotechnology group Genzyme was approaching a Friday deadline with the parties still at odds.(AFP/File/Joel Saget)... [Full Article]
(AFP/File) - French pharmaceutical giant Sanofi-Aventis Monday warned the management of Genzyme against taking threatened measures to block its 18.5-billion-dollar hostile takeover offer for the US biotechnology group.(AFP/File/Joel Saget)... [Full Article]
(AFP/File) - The headquarters in Paris of French pharmaceutical group Sanofi-Aventis. Sanofi-Aventis said Monday it had launched a hostile 18.5-billion-dollar (13.4-billion-euro) bid for US biotechnology company Genzyme, a proposal Genzyme management... [Full Article]
(AFP/File) - The Berlin office of Sanofi Aventis, April 2008. The board of directors at US biotechnology firm Genzyme has unanimously rejected an 18.5-billion-dollar takeover offer from French pharmaceutical giant Sanofi-Aventis.(AFP/File/John Macdou... [Full Article]
(AFP) - French pharmaceutical group Sanofi-Aventis unveiled Sunday a 18.5 billion dollar (14.5 billion euro) cash bid for US biotechnology firm Genzyme, or 69 dollars per share.(AFP/Joel Saget)... [Full Article]
(AFP/File) - French pharmaceutical giant Sanofi-Aventis is to take a nearly five percent stake in leading Japanese generic drug maker Nichi-Iko Pharmaceutical for about five billion yen (56 million dollars), according to the Nikkei newspaper. Sanofi-... [Full Article]
(AP) - A laboratory technician is seen at a Sanofi-Pasteur production plant manufacturing Panenza, a vaccine for the H1N1 flu virus, in Val-de-Reuil, western Paris, Monday, Oct. 19, 2009. France will begin vaccinating key medical workers against swin... [Full Article]